Let’s Reach Your Development Milestones Together
Gareth Sexton
Director, Business Development
Gareth Sexton is a forward-thinking professional who’s passionate about the next generation of healthcare, building relationships to support advanced analytics, and technologies bringing high quality medicine to patients faster. He brings over a decade of professional experience in healthcare and pre-clinical safety assessment, skilled in formulations and analytical chemistry, with knowledge of method development, validation, sample analysis for HPLC/UPLC, RP, SEC, and UV spec, among other analytical techniques.
Before joining ProtaGene, Gareth held technical/scientific, laboratory management, and client/account management roles. As an Analytical Chemistry Analyst at Charles River Laboratories, Gareth worked in formulations, focusing on both small and large molecules. He was recognized for his efforts as a key contributor in 2018 and 2019. He also worked as a Formulation Scientist and Analytical Chemistry Supervisor at Alta Sciences and notably optimized workflows and doubled instrumentation and staff. His strong desire to be client-facing led him to a Client Manager role in 2021.
Gareth holds a Bachelor of Science in Biochemistry and Molecular Biology from the University of Nevada, where he researched thiamin synthesis in transgenic plants.
Analytical Solutions from Research to Market
Biologic Therapeutics
Platform Expertise
-
mAbs
-
Bispecifics/Multispecifics
-
Recombinant Proteins—Including Complex, Highly Glycosylated Proteins
-
Multi-subunit Complexes—Protein, Nucleotide, Ligand
-
Fusion Proteins
-
Enzyme Replacement Therapies
-
ADCs and Protein Conjugates
-
PEGylated Proteins
-
Biosimilars
-
Vaccines, Including Subunit/Recombinant
Cell and Gene Therapeutic Platform Expertise
-
Capsid-based Vectors
-
bullet Created with Sketch. Complex, Envelope Vectors
-
bullet Created with Sketch. Non-viral Vectors
-
bullet Created with Sketch. Genetic Engineering